Largest pharmaceuticals by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 pharmaceuticals ranked by total assets, at AED 764.5B, ahead of Johnson & Johnson (AED 731.6B) and Sanofi (AED 516.7B). Figures as of 18 Nov 2026, 14:51 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerAED 764.5B
- Median
- AED 12.9B
- Combined market value
- AED 18.83T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | AED 764.5B | AED 592.7B | AED 103.99 | 0.54% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | AED 731.6B | AED 2.45T | AED 1,017.56 | 0.59% down | 38% up | ||
| 3 | SanofiSNY · Health Care | AED 516.7B | AED 419.3B | AED 174.60 | 0.02% up | 4% down | ||
| 4 | Merck & CoMRK · Health Care | AED 502.7B | AED 1.27T | AED 516.34 | 1.94% down | 51% up | ||
| 5 | AbbVieABBV · Health Care | AED 492B | AED 1.89T | AED 1,066.59 | 0.84% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | AED 419B | AED 1.03T | AED 662.67 | 0.98% down | 2% up | ||
| 7 | Eli LillyLLY · Health Care | AED 413.1B | AED 4.62T | AED 5,181.11 | 0.34% down | 35% up | ||
| 8 | NovartisNVS · Health Care | AED 407.5B | AED 1.09T | AED 577.57 | 1.18% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | AED 356.8B | AED 252.4B | AED 79.00 | 0.62% down | 54% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | AED 330.7B | AED 455.2B | AED 222.68 | 1.22% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | AED 318.5B | AED 666.4B | AED 384.75 | 0.00% | 17% down | ||
| 12 | GSKGSK · Health Care | AED 297.9B | AED 362.4B | AED 180.81 | 0.02% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | AED 295.9B | AED 649.4B | AED 147.35 | 1.43% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | AED 149.7B | AED 183.4B | AED 157.14 | 0.41% up | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | AED 149B | AED 365.3B | AED 3,531.04 | 0.38% up | 36% up | ||
| 16 | ViatrisVTRS · Health Care | AED 136.6B | AED 86.4B | AED 75.35 | 0.32% up | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | AED 94.2B | AED 499.8B | AED 1,971.12 | 0.47% up | 27% up | ||
| 18 | GrifolsGRFS · Health Care | AED 80.3B | AED 21.6B | AED 31.77 | 0.23% up | 1% up | ||
| 19 | Royalty PharmaRPRX · Health Care | AED 72.1B | AED 144.8B | AED 251.84 | 0.16% down | 78% up | ||
| 20 | ZoetisZTS · Health Care | AED 56.8B | AED 125.8B | AED 309.61 | 0.98% up | 29% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | AED 49.1B | AED 47.9B | AED 95.89 | 1.01% up | 20% up | ||
| 22 | GenmabGMAB · Health Care | AED 47.3B | AED 117.1B | AED 189.88 | 0.50% down | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | AED 42.8B | AED 56.8B | AED 884.47 | 0.05% up | 37% up | ||
| 24 | BeOne MedicinesONC · Health Care | AED 30.1B | AED 170.7B | AED 1,493.98 | 1.57% down | 17% up | ||
| 25 | United TherapeuticsUTHR · Health Care | AED 28.9B | AED 90.8B | AED 2,132.66 | 0.59% down | 23% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | AED 27.9B | AED 41.8B | AED 215.59 | 0.32% up | 11% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | AED 22.6B | AED 45.8B | AED 54.94 | 1.15% up | 5% up | ||
| 28 | Roivant SciencesROIV · Health Care | AED 21B | AED 102.7B | AED 141.77 | 0.28% down | 90% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | AED 18.2B | AED 76B | AED 567.65 | 1.24% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | AED 13.5B | AED 27.1B | AED 77.79 | 0.28% up | 83% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | AED 12.9B | AED 16.6B | AED 99.45 | 0.43% up | 64% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | AED 10.6B | AED 18.4B | AED 220.47 | 0.55% down | 20% down | ||
| 33 | AlkermesALKS · Health Care | AED 9.1B | AED 28.5B | AED 169.64 | 1.63% up | 58% up | ||
| 34 | InsmedINSM · Health Care | AED 8.3B | AED 97.7B | AED 445.20 | 0.53% down | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | AED 6.4B | AED 11.8B | AED 60.66 | 2.52% up | 42% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | AED 5.7B | AED 21.6B | AED 1,078.71 | 0.03% down | 43% up | ||
| 37 | Ascendis PharmaASND · Health Care | AED 5.3B | AED 64.5B | AED 983.33 | 1.27% down | 28% up | ||
| 38 | CytokineticsCYTK · Health Care | AED 5.2B | AED 26.5B | AED 190.58 | 0.46% up | 20% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | AED 5.1B | AED 22.3B | AED 157.43 | 0.29% down | 10% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | AED 4.6B | AED 35.5B | AED 1,526.64 | 1.50% down | 24% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | AED 3.9B | AED 34.8B | AED 230.54 | 0.10% up | 107% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | AED 3.4B | AED 31.3B | AED 1,119.35 | 0.09% down | 61% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | AED 3.4B | AED 18.1B | AED 103.76 | 1.44% up | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | AED 3.4B | AED 54.8B | AED 281.09 | 0.35% down | 17% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | AED 3.1B | AED 22.1B | AED 337.83 | 0.04% up | 31% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | AED 3.1B | AED 27.9B | AED 254.65 | 1.05% down | 8% down | ||
| 47 | Belite BioBLTE · Health Care | AED 2.9B | AED 23.7B | AED 583.96 | 0.81% up | 31% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | AED 2.9B | AED 33B | AED 347.11 | 0.75% up | 286% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | AED 2.8B | AED 27.9B | AED 355.30 | 1.71% up | 126% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | AED 2.8B | AED 31.5B | AED 39.41 | 0.56% up | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | AED 2.5B | AED 25.9B | AED 493.10 | 1.24% down | 7% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | AED 2.5B | AED 29.8B | AED 455.82 | 0.45% down | 46% up | ||
| 53 | ABIVAXABVX · Health Care | AED 2.4B | AED 26.8B | AED 306.39 | 1.61% up | 27% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | AED 2.2B | AED 17.7B | AED 184.85 | 1.51% down | 44% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | AED 2B | AED 16.5B | AED 150.69 | 2.40% down | 88% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | AED 1.9B | AED 17.9B | AED 318.15 | 0.41% down | 113% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | AED 1.8B | AED 24.3B | AED 357.76 | 1.13% up | 241% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | AED 1.8B | AED 29.3B | AED 422.03 | 1.46% down | 13% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | AED 1.6B | AED 14.7B | AED 107.46 | 0.41% down | 169% up | ||
| 60 | ErascaERAS · Health Care | AED 1.5B | AED 17.3B | AED 49.29 | 3.38% down | 403% up | ||
| 61 | VeradermicsMANE · Health Care | AED 560.5M | AED 19.6B | AED 464.78 | 0.72% up | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6727 AED).
Questions and answers
Which pharmaceuticals rank first by total assets?
Pfizer (AED 764.5B), Johnson & Johnson (AED 731.6B) and Sanofi (AED 516.7B) are the top three of the 61 pharmaceuticals ranked by total assets as of 18 Nov 2026, 14:51 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total assets have a combined market value of AED 18.83T as of 18 Nov 2026, 14:51 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.